Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades Univar Solns to Hold

Vertical Research Downgrades Univar Solns to Hold

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

byBenzinga Newsdesk

March 14, 2023

1 minute read

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

Analyst Ratings

Analyst Ratings for Immunocore Hldgs

By Benzinga Insights

November 2, 1:00 PM

Within the last quarter, Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

IMCR

Charlie Munger Touts Investing In China, Says Investors Can Buy Better, Stronger Companies At Cheaper Valuations There Than They Can In U.S.

By Benzinga Newsdesk

February 15, 2:48 PM

-Reuters

FXI

Jon Stewart Returns To ‘The Daily Show’ For 2024 Elections, To Help ‘Make Sense Of Insanity And Division’ In US

By Maureen Meehan

January 24, 5:51 PM

Paramount Global (NASDAQ: PARA) announced Wednesday that Jon Stewart is returning to host "The Daily Show" for the duration of the 2024 election cycle.

PARA

Barclays Maintains Equal-Weight on Newmont, Lowers Price Target to $54

By Benzinga Newsdesk

November 21, 8:43 AM

Barclays analyst Matthew Murphy maintains Newmont (NYSE:NEM) with a Equal-Weight and lowers the price target from $55 to $54.

NEM

Vertical Research Downgrades Univar Solns to Hold

Related Posts

Analyst Ratings for Immunocore Hldgs

Charlie Munger Touts Investing In China, Says Investors Can Buy Better, Stronger Companies At Cheaper Valuations There Than They Can In U.S.

Jon Stewart Returns To ‘The Daily Show’ For 2024 Elections, To Help ‘Make Sense Of Insanity And Division’ In US

Barclays Maintains Equal-Weight on Newmont, Lowers Price Target to $54